Dr. Nick Mark, professor and pulmonary critical care internist in Seattle, discusses the latest data on drug treatments and trials for COVID-19, including hydroxychloroquine, remdesivir, oseltamivir, and more.
Dr. Nick Mark, professor and pulmonary critical care internist in Seattle, discusses the latest data on drug treatments and trials for COVID-19, including hydroxychloroquine, remdesivir, oseltamivir, and more.